Amplatzer
Device Structural Heart
PDI 00811806011851
General payments
$1,196,063
Research payments
$216,328
Through program year 2025, $1,196,063 in general payments and $216,328 in research payments were reported against Amplatzer (Structural Heart).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $35,229 | 36 |
| 2024 | General | $60,398 | 57 |
| 2024 | Research | $190,640 | 68 |
| 2023 | General | $26,837 | 41 |
| 2023 | Research | $6,951 | 9 |
| 2022 | General | $1,073,599 | 3,329 |
| 2022 | Research | $18,736 | 17 |
Breakdown
The top 5 of 7 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
3,463 general · 94 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.